Associated Papers
Discriminating activating, deactivating and resistance variants in protein kinases.
Singh G et al.
Genome Medicine, 2025
41152984 (PubMed )
Supplement: 13073_2025_1564_MOESM2_ESM.xlsx › Table_S6
BRAF V600E and Novel Somatic Mutations in Thyroid Cancer of Libyan Patients.
Tounsi Guettiti H et al.
Asian Pacific Journal of Cancer Prevention : Apjcp, 2022
The yin-yang of kinase activation and unfolding explains the peculiarity of Val600 in the activation segment of BRAF.
Kiel C et al.
Elife, 2016
26744778 (PubMed )
Supplement: elife-12814-supp1.xlsx › input_random_forest
Next generation sequencing of exceptional responders with BRAF-mutant melanoma: implications for sensitivity and resistance.
Wheler J et al.
Bmc Cancer, 2015
Amplicon sequencing of colorectal cancer: variant calling in frozen and formalin-fixed samples.
Betge J et al.
Plos One, 2015
26010451 (PubMed )
Supplement: pone.0127146.s013.xlsx › Somatic_Variant_Caller
BRAF mutations in advanced cancers: clinical characteristics and outcomes.
El-Osta H et al.
Plos One, 2011
Select a paper to view details